Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

– Dysport is the first and only FDA-approved botulinum toxin for treatment of both pediatric upper and lower limb spasticity1 – – Pivotal Phase 3 study demonstrated Dysport improved spasticity ...

The treatment was already approved for pediatric upper limb spasticity earlier this year. This new approval was based on data from a phase 3 trial evaluating the safety and efficacy of Botox in 381 ...

I would venture to say many of us have issues with spasticity or tone. What is this, what does it mean, and what is the difference? My, oh, my, I was confused when they would mention these two ...

14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement disorders Interim data from the ongoing ...

(BPT) – A stroke can be a life-altering experience-one with long-term effects that can impact recovery. About 25-43% of U.S. stroke patients are affected by spasticity in the first year post-stroke.